Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others

Key opportunities in the ophthalmology devices market include the rising demand for minimally invasive surgeries, innovation ...
MarketBeat on MSN

RxSight Q2 sales sink 20% as Alcon deal bolsters 2026 outlook

Key Points Interested in RxSight, Inc.? Here are five stocks we like better. RxSight's preliminary Q2 sales fell 20% year ...

Is Alcon (SWX:ALC) Undervalued After Its RxSight Collaboration?

Alcon (SWX:ALC) shares are in focus after the company agreed a non exclusive collaboration with RxSight to co develop ...
JD Supra

Delaware Court Of Chancery Dismisses Breach Of Fiduciary Duty Claims Related To Abandoned IPO and Subsequent Settlement Proceedings

On June 26, 2026, Chancellor Kathaleen St. J. McCormick of the Delaware Court of Chancery dismissed derivative claims against certain directors and stockholders on behalf of a biotech company (the ...

Alcon collaborates with RxSight to develop adjustable PCIOLs

Alcon and RxSight partner to develop light-adjustable presbyopia-correcting IOLs, including $60M upfront and milestone payments.

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL ...